☆ 3.8 Review

A Review on the Effectivity of the Current COVID-19 Drugs and Vaccines: Are They Really Working Against the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variants?

CURRENT CLINICAL MICROBIOLOGY REPORTS (2021)

Related references

Note: Only part of the references are listed.

Review Biochemistry & Molecular Biology

Advances in research on ACE2 as a receptor for 2019-nCoV

Jie Wu et al.

Summary: The novel coronavirus (SARS-CoV-2) has caused the global spread of COVID-19, with ACE2 receptor believed to mediate virus entry. Recent studies focus on ACE2 expression changes and virus transmission, shedding light on the pathogenesis of COVID-19.

CELLULAR AND MOLECULAR LIFE SCIENCES (2021)

Add to Collection

Article Medicine, General & Internal

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK

Merryn Voysey et al.

Summary: The ChAdOx1 nCoV-19 vaccine has been shown to have an acceptable safety profile and effectiveness against symptomatic COVID-19, with higher efficacy observed in the group that received a low dose followed by a standard dose.

LANCET (2021)

Add to Collection

Article Medicine, General & Internal

Interim Results of a Phase 1-2a Trial of Ad26.COV2.S Covid-19 Vaccine

J. Sadoff et al.

Summary: The study conducted a multicenter, placebo-controlled, phase 1-2a trial, with participants randomly assigned to receive the Ad26.COV2.S vaccine. The results showed that the safety and immunogenicity profiles of the vaccine support further development.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Add to Collection

Letter Cell Biology

ACE2 mutation might explain lower COVID-19 burden in malaria endemic areas

Auley De et al.

HUMAN CELL (2021)

Add to Collection

Editorial Material Medicine, General & Internal

The BNT162b2 (BioNTech/Pfizer) vaccine had 95% efficacy against COVID-19 >= 7 days after the 2nd dose

Zain Chagla

ANNALS OF INTERNAL MEDICINE (2021)

Add to Collection

Review Microbiology

A comparative review of pathogenesis and host innate immunity evasion strategies among the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), severe acute respiratory syndrome coronavirus (SARS-CoV) and the Middle East respiratory syndrome coronavirus (MERS-CoV)

Rashed Noor

Summary: The COVID-19 pandemic caused by SARS-CoV-2 poses a global threat to public health, similar to the SARS outbreak in 2002 and the MERS outbreak in 2012. This review focuses on the mechanisms of disease progression of these viruses and their strategies to evade host immunity.

ARCHIVES OF MICROBIOLOGY (2021)

Add to Collection

Editorial Material Medicine, General & Internal

Sputnik V COVID-19 vaccine candidate appears safe and effective Comment

Ian Jones et al.

LANCET (2021)

Add to Collection

Review Immunology

Emerging SARS-CoV-2 Variants and Impact in Global Vaccination Programs against SARS-CoV-2/COVID-19

Carmen Elena Gomez et al.

Summary: SARS-CoV-2 variants with higher transmissibility and mutations in the spike protein have direct implications on infection rates and resistance to antibodies. These variants have significant impacts on medical countermeasures and human health.

VACCINES (2021)

Add to Collection

Review Medicine, Research & Experimental

Impact of virus genetic variability and host immunity for the success of COVID-19 vaccines

Wagner Gouvea Dos Santos

Summary: Despite global efforts, there are still many challenges and unanswered questions in the search for an effective way to prevent the spread of COVID-19. Scientists are currently debating issues such as reinfection of recovered individuals, duration of immunity, and the potential impact of mutations on the efficacy of vaccines. Ongoing clinical trials for various vaccines remain hopeful, but definitive conclusions on safety and efficacy will require further time and research.

BIOMEDICINE & PHARMACOTHERAPY (2021)

Add to Collection

Article Medicine, General & Internal

Profiles of current COVID-19 vaccines

Franz X. Heinz et al.

WIENER KLINISCHE WOCHENSCHRIFT (2021)

Add to Collection

Article Microbiology

Developmental Status of the Potential Vaccines for the Mitigation of the COVID-19 Pandemic and a Focus on the Effectiveness of the Pfizer-BioNTech and Moderna mRNA Vaccines

Rashed Noor

Summary: Researchers have made progress in studying the genomics of SARS-CoV-2, its similarities with SARS-CoV-1 and MERS-CoV, and the host immune evasion mechanisms of SARS-CoV-2, leading to intensive global efforts on vaccine development. The mRNA-1273 vaccine has shown to be the most effective through clinical trials, with a 95% positive outcome. However, concerns remain regarding the sustainability of vaccine efficacy against emerging variants of SARS-CoV-2.

CURRENT CLINICAL MICROBIOLOGY REPORTS (2021)

Add to Collection

Review Medicine, General & Internal

Antiviral drugs against severe acute respiratory syndrome coronavirus 2 infection triggering the coronavirus disease-19 pandemic

Rashed Noor

Summary: This review discusses various therapeutic targets and strategies for treating SARS-CoV-2, highlighting specific drugs and the importance of assessing drug repositioning candidates with related targets.

TZU CHI MEDICAL JOURNAL (2021)

Add to Collection

Review Biochemistry & Molecular Biology

SARS-CoV-2 variants evolved during the early stage of the pandemic and effects of mutations on adaptation in Wuhan populations

Annoor Awadasseid et al.

Summary: The COVID-19 pandemic caused by SARS-CoV-2 has two major variants, L-type and S-type. Investigating the variations of these variants may help assess risks and develop treatment and prevention strategies, and determine whether these mutations affect viral transmissibility and virulence.

INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2021)

Add to Collection

Letter Infectious Diseases

Analysis of angiotensin-converting enzyme 2 (ACE2) from different species sheds some light on cross-species receptor usage of a novel coronavirus 2019-nCoV

Rui Li et al.

JOURNAL OF INFECTION (2020)

Add to Collection

Article Multidisciplinary Sciences

Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation

Daniel Wrapp et al.

SCIENCE (2020)

Add to Collection

Article Infectious Diseases

Umifenovir treatment is not associated with improved outcomes in patients with coronavirus disease 2019: a retrospective study

N. Lian et al.

CLINICAL MICROBIOLOGY AND INFECTION (2020)

Add to Collection

Article Multidisciplinary Sciences

On the origin and continuing evolution of SARS-CoV-2

Xiaolu Tang et al.

NATIONAL SCIENCE REVIEW (2020)

Add to Collection

Article Multidisciplinary Sciences

Phylogenetic network analysis of SARS-CoV-2 genomes

Peter Forster et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)

Add to Collection

Review Chemistry, Multidisciplinary

Structural and functional properties of SARS-CoV-2 spike protein: potential antivirus drug development for COVID-19

Yuan Huang et al.

ACTA PHARMACOLOGICA SINICA (2020)

Add to Collection

Article Biochemistry & Molecular Biology

Development of an Inactivated Vaccine Candidate, BBIBP-CorV, with Potent Protection against SARS-CoV-2

Hui Wang et al.

CELL (2020)

Add to Collection

Article Biochemistry & Molecular Biology

Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus

Bette Korber et al.

CELL (2020)

Add to Collection

Review Public, Environmental & Occupational Health

Clinical efficacy of antivirals against novel coronavirus (COVID-19): A review

Shahamah Jomah et al.

JOURNAL OF INFECTION AND PUBLIC HEALTH (2020)

Add to Collection

Review Pharmacology & Pharmacy

Efficacy and safety of current therapeutic options for COVID-19-lessons to be learnt from SARS and MERS epidemic: A systematic review and meta-analysis

Han Zhong et al.

PHARMACOLOGICAL RESEARCH (2020)

Add to Collection

Review Virology

COVID-19 Vaccine: A comprehensive status report

Simran Preet Kaur et al.

VIRUS RESEARCH (2020)

Add to Collection

Review Pediatrics

Vaccine Against Covid-19 Disease - Present Status of Development

Ashok Kumar Dutta

INDIAN JOURNAL OF PEDIATRICS (2020)

Add to Collection

Article Medicine, General & Internal

Phase 1-2 Trial of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine

Cheryl Keech et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Add to Collection

Article Biotechnology & Applied Microbiology

A comparative study between the severe acute respiratory syndrome-Coronavirus-2, severe acute respiratory syndrome coronavirus, and the middle east respiratory syndrome coronavirus

Syed Abdullah Ibn Asaduzzaman et al.

BIOMEDICAL AND BIOTECHNOLOGY RESEARCH JOURNAL (2020)

Add to Collection

Review Pharmacology & Pharmacy

Drug targets for corona virus: A systematic review

Manisha Prajapat et al.

INDIAN JOURNAL OF PHARMACOLOGY (2020)

Add to Collection

© Peeref 2019-2024. All rights reserved.